REXULTI PATENTS FACING OPPOSITIONS
REXULTI facing oppositions at the European Patent Office (EPO)
| Patent Number | Title | Applicants | Legal Status | Legal Status Date | Oppositions | Activity Alert |
|---|---|---|---|---|---|---|
| EP2767285B1 | Tablet including 7-[4-(4-benzo[beta]thiophen-4-yl-piperazin-1-yl) butoxy]-1h-quinolin-2-one or salt thereof | Granted and Under Opposition | Oct 25, 2019 |
MAIWALD PATENT
TEVA PHARMACEUTICAL
|